Skip to Main Content
BLACK FRIDAY SALE

60% off Quiver Premium for new subscribers

...

Use Promo Code:

BLACKFRIDAY26
×
Quiver Logo Get a Free Trial on Quiver Premium Today!
Back to News

HERON THERAPEUTICS ($HRTX) Releases Q3 2026 Earnings

None

HERON THERAPEUTICS ($HRTX) posted quarterly earnings results for Q3 2026 on Monday, November 9th. The company reported earnings of -$0.03 per share, missing estimates of -$0.03 by $0.00. The company also reported revenue of $35,250,000, missing estimates of $38,250,000 by $-3,000,000.

You can see Quiver Quantitative's $HRTX stock page to track data on insider trading, hedge fund activity, congressional trading, and more.

EARLY ACCESS
Receive HRTX Data Alerts
Real-time alerts on filings, insider trades, and market signals — before everyone else.
Get Alerts →

HERON THERAPEUTICS Hedge Fund Activity

We have seen 69 institutional investors add shares of HERON THERAPEUTICS stock to their portfolio, and 69 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

Check out the Quiver Quantitative API to build on top of data on congressional stock trading, insider transactions, hedge fund moves, and more.

Add Quiver Quantitative to your preferred sources on Google Google News Logo

Suggested Articles